Podcasts about neurotech

What does it look like to take a neuroscience degree far beyond the lab? In this episode, we explore a career path that crosses scientific research, government regulation, and biotech entrepreneurship with Dr. Amanda Wiggins, CEO of The cGP Lab. Amanda began her career investigating neurodegeneration and cortical spreading depression. Over time, her passion for real-world impact led her into public policy—where she helped shape New Zealand's Human Tissue Act and advised on regulations for stem cell research and genetic technologies. Today, she leads a company advancing neuroprotective health supplements based on cyclic Glycine-Proline (cGP), a molecule with growing potential in aging and cognitive health. We talk about: How to navigate transitions between academia, government, and business The challenges of working across disciplines—and how to build confidence in new spaces Lessons learned from leading regulatory change and scaling innovation Amanda's work at The cGP Lab and the science behind cGP's potential in brain health Advice for scientists who want to move into leadership, entrepreneurship, or public engagement This conversation is for anyone considering a non-linear career in neuroscience or wondering how to apply scientific training in new and meaningful ways. Chapters: 00:00:02 - Bridging Neuroscience and Biotech Innovation 00:04:06 - FDA Approval of Trofinetide for Rett Syndrome 00:07:27 - My Journey in Science and Identity 00:09:22 - Pursuing a PhD in Melbourne 00:11:55 - Choosing a PhD Topic 00:17:26 - Challenges and Motivation in PhD Journey 00:20:54 - Transition from Academia to Regulatory Work 00:22:52 - Transitioning from Academia to Policy 00:25:51 - Advising on the Human Tissue Act 00:29:18 - Advocating Biotechnology in New Zealand 00:33:51 - Regulations and Challenges in Biotechnology 00:37:49 - Newborn Blood Screening and Research Ethics 00:41:22 - Transitioning from Science to Biotech 00:46:04 - Challenges of Startup Success 00:48:34 - Journey to Neuroactive Innovation 00:55:23 - Mentorship and Startup Advice 00:58:49 - Dementia Prevention and Early Detection 01:02:03 - Exploring Alzheimer's Research Frontiers 01:06:45 - Advancing Your Neurocareer About the Podcast Guest:

What if the key to tomorrow's scientific and technological breakthroughs lies in today's science fiction? In this special-format episode of Neurocareers: Doing the Impossible!, we step outside our typical interview structure to explore the power of imagination as a driving force behind scientific innovation. Our guest, Dante Therese—science fiction author, screenwriter, and creator of The Base trilogy—brings a fresh perspective on how fiction, research, and creativity intersect. Her research-informed storytelling weaves together suspense, military science, and real-world advances like brain-computer interfaces (BCIs), robotic limbs, synthetic cartilage, and speech restoration technologies. But this conversation goes far beyond the page. You'll discover how to: Use your imagination as a tool to generate new ideas—especially when you're not yet ready to implement them in a lab. Translate complex, innovative thinking into writing to build clarity, confidence, and even prototypes for future projects. Tap into different cognitive modes—focused and diffuse thinking—to unlock creativity and solve hard problems with new insight. Stay resilient and inspired even if your ideas do not 'fit' the current day standards. Apply storytelling strategies and character development to create your own science fiction story! Whether you're a neurotech innovator, a scientist in search of creative spark, or a writer fascinated by emerging technology, this episode offers a refreshing reminder that the future often begins in imagination—and that doing the impossible sometimes starts with telling the story. Chapters: 00:00:01 - Writing and Creativity 00:02:52 - The Importance of Imagination and Creativity 00:14:07 - Exploring Imagination and Insect Inspiration 00:19:59 - Exploring Idea Generation and Creativity 00:24:47 - Writing and the Fun of Elimination 00:29:05 - Persistence in Search and Recovery 00:33:32 - Persistence in Creative Endeavors 00:36:30 - Reviving Abandoned Spaces Through Imagination 00:40:57 - The Role of Villains in Storytelling 00:44:03 - Responsibility of Writers and Creators 00:52:07 - Writing Process and Character Development 00:54:55 - Character-Driven Science Fiction Writing 01:02:00 - Exploring Lives Beyond One Sentence 01:05:00 - Impact of Farming Background on Students 01:11:37 - Identical Twins and Their Communication 01:16:10 - Daily Writing Discipline and Growth 01:18:24 - Finding Dante's Books 01:21:24 - AI's Impact on Writing and Thinking Ready to step inside a world built from plot twists and pill bugs? Tune in now.   About the Podcast Guest: Dante Terese is a suspense fiction author and screenwriter who conjures gripping worlds where science, story, and imagination collide. Best known for The Base—a high-stakes thriller series where military scientists design insect-inspired technology—Dante weaves together cutting-edge research and character-driven storytelling to build immersive realities that blur the line between fiction and future. Driven by childlike curiosity and an insatiable love for details, Dante explores how creative thought can unlock real-world innovation. Whether through writing, filmmaking, or character alchemy, she believes stories have the power to reimagine not just the world we live in—but the one we could.

SomX's Hue Penson, Andrew Hair and Hollie Ruda dive into the weeks' healthtech stories.00:00 - Intro 01:25 - Musk's Neuralink raises $650 million in latest funding as clinical trials begin + A Neuralink Rival Just Tested a Brain Implant in a Person12:10 - atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies20:13 - NHS England pauses ‘ground-breaking' AI project following GP data concerns

What if clinical trials could save lives and launch your global medtech career? What happens when you combine cutting-edge medical devices, international clinical trials, and a relentless drive to create real-world impact? Meet Julio M. Clark — CEO of bioaccess® and host of the LatAm MedTech Leaders podcast — who turned a one-man regulatory operation into a pioneering contract research organization transforming healthcare across Latin America. In this episode of Neurocareers: Doing the Impossible!, we explore: How Latin America became a hub for first-in-human clinical trials The unique challenges and opportunities of medical device research in global markets Why AI is revolutionizing everything from informed consent to trial proposals Career pathways for biomedical engineers and clinicians in medtech startups The mindset needed to build impactful ventures from scratch — even after failure Julio shares the entrepreneurial journey behind bioaccess®, the future of medtech clinical trials, and how YOU can contribute to life-saving innovation—even if you're just starting out. Whether you're a neurotech enthusiast, aspiring clinical researcher, or global health innovator—this episode will inspire you to think bigger, act bolder, and, most importantly, choose the right table.

Join us in this episode for a conversation with Jen French and Ian Burkhart, leaders of neurotech development movements and users of implanted neurological devices. Our guests share briefly about their experience with implanted devices, and then the conversation zooms in on exciting recently developments in implantable brain-computer interface (iBCI) and electrical simulation options such as epidural spinal cord stimulation (eSCS). Having been through the process, Jen and Ian deliberate on the importance and steps in engaging people with the lived-experience of paralysis in the development of meaningful clinical outcome assessments for clinical trials. Safety and aversion to electing for implantation are also discussed. We hope you enjoy this episode with Jen French and Ian Burkhart on these exciting neurological technologies and the role of lived-experience in neurotech now and in the future.

What does it take to challenge the deadliest brain tumors with sound waves? How do you scale a medtech startup into a multinational clinical company? And what advice can a top neuro-oncology innovator offer to those hoping to follow a similar path? Welcome to Neurocareers: Doing the Impossible! — The podcast where we explore the extraordinary journeys of those advancing the future of neuroscience and neurotechnology. I'm your host, Dr. Milena Korostenskaja. Today we're speaking with Dr. Michael Canney, the Chief Scientific Officer at Carthera, a clinical-stage medtech company revolutionizing brain therapy through therapeutic ultrasound. With over 15 years of experience in MedTech innovation, Dr. Canney specializes in glioblastoma, neurodegenerative diseases, and therapeutic ultrasound drug delivery. He's currently leading the SONOBIRD Phase 3 clinical trial across 40 sites in the U.S. and Europe, pushing the boundaries of what's possible in treating recurrent glioblastoma. Michael's career spans everything from FDA regulatory strategy to high-impact academic collaborations. He's co-authored over 50 peer-reviewed papers in top-tier journals and 14 patent families. But what truly drives him is improving patient outcomes and bringing hope to some of the most challenging areas in brain health. Whether you're curious about clinical trials, neuro-oncology innovations, or carving out your own career in medtech, this conversation is packed with insight and inspiration. Let's dive in! Chapters: 00:00:01 - Revolutionizing Brain Therapy with Ultrasound, Introducing Dr. Michael Canney 00:04:49 - Advancements in Ultrasound for Drug Delivery 00:10:15 - Innovative Ultrasound for Drug Delivery 00:13:49 - Innovative Ultrasound Approach for Tumor Treatment 00:16:02 - Understanding Blood-Brain Barrier Disruption 00:19:28 - Device Overview and Design Features 00:21:32 - Ultrasound Technology for Tumor Treatment 00:24:15 - Device Implantation in Cancer Treatment 00:28:34 - Challenges in Glioblastoma Treatment Trials 00:31:46 - Dr. Michael Canney's Journey into Ultrasound Research 00:36:15 - Starting a Postdoc Journey 00:39:20 - Career Development in Neuroscience 00:43:31 - Building a Startup Team 00:47:38 - Hiring for Clinical Application Specialists 00:52:16 - Growth of Careers in Neurotechnology 00:54:26 - Using AI in Clinical Trials 00:57:13 - Challenges in Medical Device Approval 00:59:41 - Overcoming Challenges in Medical Innovations 01:02:20 - Clinical Trials and Company Information About the Podcast Guest: Michael Canney, Ph.D., is Chief Scientific Officer at Carthera, a clinical-stage medtech company advancing brain therapy through innovative ultrasound-based devices. A co-author of more than 50 peer-reviewed articles, he specializes in neuro-oncology, glioblastoma and neurodegenerative diseases. At Carthera, he is responsible for leading scientific collaborations with academic institutions, organizing U.S. clinical trials and more. Connect with Dr. Canney on LinkedIn: https://www.linkedin.com/in/michael-canney-ph-d-42457b5/ Learn more about Carthera: https://carthera.eu/ Get familiar with the Sonobird clinical trial: https://sonobird.eu/ About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02 Review of episode 32 00:55 Intro of Nicole Fram, MD 01:16 Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24 Meeting about complications from cataract surgery, what do you think is the next big phase on how we're going to handle complications with technology? 04:05 Psychology of managing patients/conveying care 05:42 What advice do you give to people who are starting their career? 06:50 Intro of Kerry Solomon, MD 09:30 What do we often get wrong with cataract surgery and what do we often get right? 10:25 How do you stay an entrepreneur and a leading physician? 11:55 What is Operation Sight? How did you create it? 14:19 Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30 Intro of Vance Thompson, MD 21:24 What's it like to be ASCRS president? 21:59 What is BRiCS and why is it important? 23:54 You've created a culture; can you talk about that culture you've created at your institute? 29:30 Tell us about your winery! 33:28 Intro of Steve Speares 36:45 ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00 As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57 Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19 Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29 Preview of episode 34 52:09 Give us your feedback 52:40 Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.

It's New Tunesday: new releases from the past week! Give the bands a listen. If you like what you hear, support the bands! Today's episode features new releases by DiarBlack (ft. Helga Dyrfinna), Midsummer Ex, Neurotech, Stars Crusaders, Missing in Stars, Modulo One, Fermion, Mari Kattman, Megan McDuffee, Analog 80, Freaky Mind, Bleeding Corp, Shad Shadows, Dunkelwald, Owls, No, Luminance, Ezra Seven (ft. Virgo Supercluster), Equitant (ft. Yasmin Gate), Seasurfer, Deceits, Mark E Moon, and Fuzzle!

How do you turn massive clinical imaging data into insights that change lives? What does it take to move from a psychology undergrad to a pioneering role in pediatric brain research? And how can coding, connectomics, and curiosity shape a meaningful clinical career in neuroscience? In this inspiring episode of Neurocareers: Doing the Impossible!, we sit down with Dr. Puck Reeders, Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital. From her early days in Curacao to building novel neuroimaging pipelines in one of the nation's oldest pediatric epilepsy programs, Dr. Reeders shares her unique career path—and how she helps decode complex brain networks to improve surgical outcomes for children with intractable epilepsy. We explore: How connectomics and diffusion imaging guide surgical planning Her innovative research on white matter networks and neuromodulation responses The steep but rewarding path from zero coding skills to advanced tractography Tips for transitioning from psychology to clinical neuroscience Career advice for anyone eager to enter research-focused medical settings Whether you're a student exploring future careers, a neuroscientist curious about clinical impact, or just fascinated by how science meets medicine—you'll walk away informed and inspired. Chapters: 00:00:00 - Insights from a Neuroscience Research Scientist 00:03:00 - Functional Mapping Techniques for Epilepsy 00:08:43 - Transitioning from Medical School to Psychology 00:13:10 - Research Gaps in Epilepsy 00:17:10 - Understanding Connectomics in Epilepsy Treatment 00:21:53 - Combining Imaging Techniques in Research 00:24:50 - Coding Challenges in Research 00:27:12 - Coding Journey in Neuroscience 00:28:51 - Learning to Code: A Personal Journey 00:32:39 - The Importance of Networking 00:34:30 - Art's Role in Science Communication 00:37:38 - Landing a Job Through Networking 00:41:22 - Research Opportunities in Connectomics 00:46:49 - Exploring Diverse Career Opportunities 00:51:38 - Job Search Tips and Strategies 00:54:39 - Tips for Job Applications and Interviews 00:59:46 - From Medicine to Neuroscience Research 01:02:06 - Clinical Research and Pediatric Epilepsy About the Podcast Guest: Dr. Puck Reeders is a Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital in Miami, Florida https://www.nicklauschildrens.org/home Her work focuses on investigating aberrant brain networks in children with intractable epilepsy, applying advanced neuroimaging techniques to improve clinical outcomes in pediatric neurology. Originally from the Netherlands and raised on the island of Curaçao, Dr. Reeders brings a global perspective to her research. She holds a Bachelor of Science in Psychology and Chemistry from the University of Miami, and a PhD in Cognitive Neuroscience from Florida International University, where she also completed her postdoctoral training in the Allen Neurocircuitry and Cognition Lab. Dr. Reeders has over nine years of experience working with functional MRI (fMRI) and diffusion-weighted imaging (DWI) in both adults and children. Her current research explores the structural connectomics of pediatric epilepsy, the development of clinical imaging pipelines to detect white matter abnormalities, cortical dysplasias, and automated SPECT subtractions—bringing together cutting-edge science with translational clinical impact. Her expertise spans: Neuroimaging and clinical pipeline development Data analysis and scientific coding Translational neuroscience and surgical planning support Research project design and academic mentoring Outside of the lab, Dr. Reeders shares insights into neuroscience careers and research life on her educational Instagram: @Drpucky You can also connect with her professionally on LinkedIn:  https://www.linkedin.com/in/puckreeders/  About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

How does a personal passion project turn into a groundbreaking neurotech startup? In this episode, we sit down with Dr. Ildar Rakhmatulin to explore his remarkable journey from academia to entrepreneurship — and how a global chip shortage sparked the creation of Pi-EEG, a Raspberry Pi-based BCI device that's transforming neuroscience education. Discover how Ildar's open-source innovation makes brain-computer interfaces more accessible, engaging both the research community and curious learners. We dive into the evolution of his work, from the RMBCI project to the Pi-EEG platform, and explore its exciting integration with tools like ChatGPT and P300 gaming applications. In this episode, you'll learn about: The evolution from RMBCI to the Pi-EEG device The power of open-source collaboration in neurotech How Pi-EEG connects with ChatGPT and brain-signal-based gaming The educational impact on neuroscience and signal processing Join us for an inspiring conversation on turning persistence and creativity into cutting-edge innovation in the world of brain-computer interfaces. Chapters: 00:00:02 - Launching Personal Projects in Neurotech 00:05:12 - Development of the Pyg Device 00:09:31 - Benefits of Open Source Collaboration 00:13:55 - Challenges in EEG Device Development 00:17:16 - Motivation Behind Passion Projects 00:20:00 - Introducing the Latest PiEG Device 00:25:49 - Measuring Multiple Biological Signals 00:29:02 - Introduction to EEG Signal Processing 00:31:06 - Understanding EEG and Signal Processing 00:38:52 - Finding Passion in Neurotechnology Careers 00:43:50 - Balancing Work and Passion Projects 00:47:49 - Real-World Problems and Neurotechnology Trends 00:50:43 - Careers in Neurotechnology 00:59:38 - Advancing Your Neurocareer About the Podcast Guest: Dr. Ildar Rakhmatulin is a scientist, engineer, and entrepreneur based in the United Kingdom, working at the intersection of neuroscience, biosignal processing, and brain-computer interface (BCI) innovation. He is the founder of PiEEG, an open-source, low-cost BCI platform built on Raspberry Pi, designed to democratize access to neurotechnology for students, researchers, and developers around the world. With a Ph.D. in hardware and software engineering, Dr. Rakhmatulin specializes in real-time biodata acquisition, including EEG, PPG, and EKG, and applies machine learning and deep learning algorithms to brain signal classification. His engineering work bridges research and accessibility—helping transform neuroscience education and experimentation through affordable, modular tools.

In this illuminating episode of Research Renaissance, host Deborah Westphal sits down with Ana Maiques, CEO and co-founder of Neuroelectrics, a groundbreaking company at the forefront of non-invasive brain stimulation technology. Together, they explore the intersection of neuroscience, entrepreneurship, and innovation, diving deep into how electrical brain stimulation is changing the future of treatment for neurological disorders like epilepsy, depression, and Alzheimer's.Ana shares her unconventional journey into entrepreneurship, her commitment to ethical tech, and the long road to FDA approval. She also discusses the development of Neuroelectrics' personalized brain therapies and the potential for at-home use of medical-grade neurostimulation devices.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.

How can innovative technologies like VR and neuromodulation improve how we understand and treat PTSD? How can curiosity and leadership open doors in neuroscience and mental health? What does it take to build a meaningful career impacting millions? In this inspiring episode of Neurocareers: Doing the Impossible!, Dr. Milena Korostenskaja (Dr. K) sits down with Prof. Deborah Beidel — Trustee Chair and Pegasus Professor of Psychology and Medical Education, and Executive Director of UCF RESTORES — to explore a career built on courage, innovation, and compassion. Career Development with Purpose Prof. Beidel shares how her early desire to be a detective evolved into a lifelong career as a clinical psychologist. Guided by curiosity, she carved her path by listening deeply to patient stories, identifying underexplored research gaps, and taking bold steps into leadership roles. “Not everything works out, but everything's a learning experience,” she says — a mantra that defines her career resilience. She also offers valuable career advice for students, including: Why it's okay not to know your path early on How to create your own opportunities instead of waiting for them Why leadership is often about building — people, programs, and impact How to approach mentors, research projects, and rejection with strategy and grace This episode features questions submitted by members of the Neuroscience Alliance at UCF — a student group making waves in shaping the future of neuroscience education (listen to their episode here: https://www.neuroapproaches.org/podcast/episode/f59186d5/neuroscience-alliance-at-ucf-with-sudeepta-matha-andrei-nesterenko-mae-torra-charisse-melendez-and-prof-kiminobu-sugaya). The Neuroscience of PTSD Prof. Beidel dives deep into the evolving understanding of post-traumatic stress disorder. Listeners will learn: Why PTSD is not just a psychological issue, but a sensory and neurological one The overlooked power of smell in trauma memory and treatment How PTSD affects more than just veterans — including first responders, mass shooting survivors, and even ICU patients She also introduces her groundbreaking work with UCF RESTORES, where she leads a three-week, evidence-based treatment program using virtual reality, group therapy, and individualized exposure therapy. “It's like putting out a wildfire with every hose you've got,” she says. New Frontiers in Neurotechnology Prof. Beidel talks about using evoked potentials to differentiate between trauma responses in combat veterans, and the potential of neuromodulation and AI to personalize PTSD treatment. She emphasizes the need for secure, clinician-friendly tech that integrates seamlessly into existing workflows. “The future of PTSD diagnosis and treatment may rely on tools we're just beginning to understand — and the students listening today may be the ones to build them.” Whether you're considering graduate school, already in research, or exploring clinical applications of neuroscience, this episode is a must-listen. Tune in and take notes from one of the leading voices in trauma recovery and career mentorship in psychology and neuroscience. Learn more about Prof. Beidel's work at ucfrestores.com

Welcome back to New Insight with Veeral Sheth, MD! Veeral Sheth, MD, is joined by Rich Small, the CEO of Neurotech, to discuss the historic approval of revakinagene taroretcel (ENCELTO) a groundbreaking encapsulated cell therapy for macular telangiectasia type 2 (MacTel). This approval marked the first and only FDA–approved treatment for MacTel, a neurodegenerative disease of the retina that can cause progressive and irreversible vision loss. Speaking with Sheth, Small recounted the long journey of Neurotech, which began in 2007, emphasizing the perseverance required to bring ENCELTO to market. He detailed his transition from Chief Financial Officer to CEO in 2016 and highlighted his team's commitment, many of whom have been with the company for over a decade. The conversation explored the scientific foundation of ENCELTO, which uses genetically modified cells to release neurotrophic factors that protect photoreceptors in the retina. Unlike previous treatments that relied on best corrected visual acuity (BCVA) as a clinical endpoint, ENCELTO's approval was enabled by advancements in imaging technology that allowed for direct measurement of photoreceptor health. Sheth and Small discussed the ideal patient profile for ENCELTO, noting that early intervention is key to preserving vision in MacTel patients. With ENCELTO's approval secured, Small indicated the next step is widespread adoption, introducing ENCELTO.com as a patient service hub designed to streamline diagnosis, treatment, and access to care.  #Ophthalmology #Podcast #RareDisease

How can you take your career growth into your own hands? In this episode of Neurocareers: Doing the Impossible!, we're diving into a story of initiative, inspiration, and empowerment led by the students of the Neuroscience Alliance at the University of Central Florida (UCF). Faced with a desire to expand their educational and career opportunities, these incredible students didn't wait for the right resources to come their way—they created them! The Neuroscience Alliance was founded with a mission to promote awareness, research, and volunteer opportunities in neuroscience while building professional connections between students and faculty. In this episode, we're joined by the remarkable minds behind the Neuroscience Alliance at UCF. They'll share their journey, the challenges they faced, and the benefits they've experienced by creating such a vibrant and supportive organization. More importantly, they'll provide practical advice and inspiration for students worldwide who want to take charge of their own education and career development. Ready to discover how you can create opportunities, build networks, and make a real difference in your field? Tune in to hear the story of the Neuroscience Alliance and learn how you can bring similar initiatives to life at your university. Let's explore how students are redefining neuroscience education—one bold step at a time! About the Podcast Guests: The Neuroscience Alliance (NSA) at the University of Central Florida The NSA is a student organization committed to advancing awareness, research, and volunteer opportunities in neuroscience. It serves as a bridge between students and faculty, offering insights into current research and future career opportunities. The alliance takes a multidisciplinary approach to neuroscience, linking it with fields like medicine, psychology, biotechnology, psychiatry, and more. NSA organizes various activities, including the Central Florida Brain Bee—a competition that challenges high school students' knowledge of neuroscience, aiming to foster interest and encourage future careers in this dynamic field. Join the Neuroscience Alliance: Email: neuroscienceallianceucf@gmail.com  Participate in the Central Florida Brain Bee: Contact Sudeepta Matha: sudeepta.matha@ucf.edu  These platforms provide fantastic opportunities for both collegiate and high school students to delve deeper into neuroscience, offering both educational and practical experiences in the field. For more information about the Neuroscience Alliance, visit https://med.ucf.edu/mdna/neuroscience-alliance-at-ucf/    Sudeepta Matha Undergraduate Student & Neuroscience Advocate Sudeepta Matha is a 4th-year undergraduate student at the University of Central Florida, majoring in Psychology on the Neuroscience Track with a minor in Cognitive Sciences. Passionate about neuropsychology, Sudeepta focuses on researching the interplay between neurodevelopment, autism, and behaviors like suicidal ideation and non-suicidal self-injury. As Executive Manager of the Central Florida Brain Bee, Sudeepta has advanced through roles as a volunteer, PR Manager, and Event Manager, demonstrating dedication to neuroscience education and outreach. Sudeepta plans to pursue a Ph.D. in neuropsychology, aiming to uncover new insights into neurodevelopmental disorders and suicidality.    Andrei Nesterenko Emerging Neuroscientist & Biomedical Explorer Andrei Nesterenko is a third-year undergraduate at the University of Central Florida, majoring in Biomedical Neuroscience with minors in Political Science and Rhetoric and Writing. His research spans multiple areas of neuroscience, with two current projects focusing on noninvasive intracranial pressure monitoring and the intersection of neuroscience and the legal system. As a former Public Relations Manager and the current Research Manager for the 2024 Central Florida Brain Bee, Andrei has dedicated his efforts to increasing access to basic neuroscience education in the Greater Orlando area and beyond. Following graduation and future post-baccalaureate research opportunities, Andrei plans to pursue a joint MD-PhD degree in either biomedical or behavioral neuroscience.   Charisse Melendez Future Audiologist & Community Educator Charisse Meléndez is a third-year student at the University of Central Florida majoring in Communication Sciences and Disorders with a minor in Spanish. Her future career goals are to pursue a doctorate in audiology, specializing in pediatrics and musicians, and lead an organization with a humanitarian focus. Her research interests include minimizing cochlear implant candidacy discrepancies between English and Spanish-speaking individuals, evaluating the relationship between hearing and memory, and the interrelationships between hearing and other diagnoses (for differential diagnosis). She is currently the PR manager for the Central Florida Brain Bee, a neuroscience competition under the NSA. Some of her personal interests include playing musical instruments at her church (bass, guitar, and piano), candle making, and working out.   Mae Torra Biomedical Science Student & Environmental Advocate Mae Torra is a 2nd-year undergraduate student at the University of Central Florida, majoring in Biomedical Sciences on the Neuroscience Track with minors in Environmental Studies and Genomics & Bioinformatics. Over the summer of 2024, they conducted research in Brown University's Computational Neuroscience cohort through their Leadership Alliance SR-EIP. In the Neuroscience Alliance at UCF, they have served as a STEM Day Director, Event Director, and Secretary, with contributions ranging from designing educational activities for community outreach to hosting research workshops. They plan to pursue a Ph.D. in Behavioral Neuroscience, and are currently exploring interdisciplinary connections between neuroscience and ecology through a literature review on pollinator behavior.   Prof. Kiminobu Sugaya Distinguished Professor & Researcher in Neuroscience Prof. Kiminobu Sugaya is a leading neuroscience researcher at UCF. He is a mentor within the Neuroscience Alliance, guiding students and research in neurodegenerative diseases and stem cell therapy. For more about his work or to get in touch, visit his faculty page at UCF Department of Neuroscience: https://med.ucf.edu/biomed/person/dr-kiminobu-sugaya/   About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Chaque mois, le coach Didier Acouetey, président d'AfricSearch, conseille un jeune entrepreneur sur ses difficultés. En deuxième partie, débat avec des patrons de PME du continent. Cette semaine, quand les diplômés africains ne rentrent pas au pays, un gâchis pour les PME ? Partie 1 : conseils à un jeune entrepreneur- Didier Acouetey, président du cabinet AfricSearch- Tinos, 25 ans, créateur de NerdX Digital, société qui conseille les entreprises et les aide à créer des solutions numériques bas carbone Cotonou, Bénin. Partie 2 : Le partage de la valeur : - Cyrille Nkontchou, partner chez Enko Capital, groupe panafricain de capital-investissement-  Abdoulaye Mbaye, fondateur et dirigeant de Neurotech, un opérateur panafricain de services informatiques présent dans 6 pays- Didier Acouetey, président du cabinet AfricSearch. Programmation musicale : ► +225 - Le Juiice & Ivorian Doll► Bad Habit - Aguero Banks, Zazikafa.

Chaque mois, le coach Didier Acouetey, président d'AfricSearch, conseille un jeune entrepreneur sur ses difficultés. En deuxième partie, débat avec des patrons de PME du continent. Cette semaine, Quand les diplômés africains ne rentrent pas au pays, un gâchis pour les PME ? Partie 1 : conseils à un jeune entrepreneur- Didier Acouetey, président du cabinet AfricSearch- Tinos, 25 ans, créateur de NerdX Digital, société qui conseille les entreprises et les aide à créer des solutions numériques bas carbone Cotonou, Bénin Partie 2 : Le partage de la valeur : - Cyrille Nkontchou, partner chez Enko Capital, groupe panafricain de capital-investissement-  Abdoulaye Mbaye, fondateur et dirigeant de Neurotech, un opérateur panafricain de services informatiques présent dans 6 pays- Didier Acouetey, président du cabinet AfricSearch. Programmation musicale : ► +225 - Le Juiice & Ivorian Doll► Bad Habit - Aguero Banks, Zazikafa

The technology was previously funded by the Foundation for the treatment of retinitis pigmentosa and dry age-related macular degeneration.

Tom Kalil is the CEO of Renaissance Philanthropy. Tom served in the White House for two presidents (Obama and Clinton) and in collaboration with his team worked with the Senate to give every federal agency the authority to support incentive prizes for up to $50 million. Tom also designed and launched dozens of White House science and technology initiatives, including the $40 billion National Nanotechnology Initiative, announced by President Clinton; The BRAIN Initiative, announced by President Obama; The Next Generation Internet initiative, announced by President Clinton and Vice President Gore; and initiatives in advanced materials, robotics, smallsats, data science, and EdTech. About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Are you wondering how to pivot from academia to the neurotech industry without starting from scratch? Many assume that moving from a PhD to industry means leaving much of their academic experience behind, but that's not necessarily the case. Welcome to this episode of Neurocareers: Doing the Impossible!, where we uncover how advanced academic skills can be a powerful asset in the neurotech sector. Today, we're honored to have Dr. Mustafa S. Hamada, Chief Science and Product Officer at Mendi Innovations in Sweden, share invaluable insights on leveraging PhD skills to break into and excel in neurotechnology. Dr. Hamada, a trailblazer in integrating neuroscience with product innovation, will guide us through how we can translate academic expertise into industry success. He'll reveal what industry employers are looking for during interviews, discuss the benefits of being a generalist versus a specialist, and provide tips on navigating the job market with your unique skills. Moreover, we'll dive into the strategic choices that can shape your career path: selecting the right company size, the importance of mentorship, and working in start-up environments. Dr. Hamada will also touch on the impact of AI in neurotech, compare the job markets in Europe and the US, and forecast the future of the industry. If you're eager to learn how your PhD can open doors in the neurotech field, and you want to know what it takes to stand out to employers and thrive in this dynamic industry, then tune into Dr. Hamada's expert advice and personal journey. Transform your academic achievements into your industry advantage with insights from a leading expert in neurotech. Let's discover how to leverage your PhD for success in the fast-evolving world of neurotechnology together! About the Podcast Guest: Dr. Mustafa S. Hamada is the Chief Science and Product Officer at Mendi Innovations, a neurotechnology startup in Sweden. Dr. Hamada drives the integration of advanced neuroscience into innovative product development, focusing on neurotechnology, behavioral design, and AI to enhance brain health solutions. He was also a recipient of the Grand Prize for Engineering in Innovation 2024. Work email: mustafa@mendi.io LinkedIn: www.linkedin.com/in/mustafashamada   About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Jennifer Garrison, PhD, is Co-Founder and Director of the Global Consortium for Reproductive Longevity and Equality (GCRLE) and an Assistant Professor at the Buck Institute for Research on Aging. She also holds appointments in the Department of Cellular and Molecular Pharmacology at the University of California, San Francisco (UCSF) and the Leonard Davis School of Gerontology at the University of Southern California (USC). She is a passionate advocate for women's health and is pioneering a new movement to advance science that is focused on female reproductive aging. Her lab studies the role of mind-body communication in systemic aging, and how changes in the conversation between the ovary and brain during aging may lead to the onset of reproductive decline in females.About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA. Welcome to the Eyeluminaries podcast :02 Review of episode 30 3:23 Intro of Paul Singh, MD 3:40 What are the future trends in glaucoma you're most excited about? 5:10  What challenges do you see in running your practice that didn't exist in your dad's day? 8:36 You've got a great medical office, a very busy consulting and research practice, you play in a band and you have a young family. What advice would you give others in keeping it all in balance? 12:09 Besides your dad and the two of us, who do you look up to in eye care? 14:45 Singh sings a Funkadesi song 18:16 Intro of Candy Simerson 20:36 When you come into a new practice to consult, what are the most common areas you see where improvement can be made? 21:41 What about the finances? What areas in finances do you see where improvement can be made? 24:27 In your many years in ophthalmology, what are the biggest challenges you've experienced? 26:10 What type of practice should consider a sale to private equity? What type of practice should not? 29:34 What advice would you give a company representative who wants to win business from a big ophthalmology practice? 32:29 Intro of the Goldbergs 36:25 Jeff Goldberg, MD, PhD 36:50 Roger Goldberg, MD, MBA 37:21 Jeff, why glaucoma instead of retina? 38:43 Roger, why retina instead of glaucoma? 39:37 Mazzo discusses neuroprotection in retina and glaucoma. 41:14 What is entrepreneurship like today? What's your advice? What is challenging and what is positive? 43:10 Mazzo discusses being realistic about innovations. 48:30 What is private practice like today? 49:31 How do cornea specialists better understand glaucoma specialists? 53:05 How do cornea specialists better understand retina specialists? 54:13 Tell us about emmecell. 55:50 Preview of episode 32 59:19 Give us your feedback 1:00:18 Thanks 1:00:30 Jeffrey Goldberg, MD, PhD, is professor and chair of ophthalmology at the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine. Roger Goldberg, MD, MBA, board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society and the American Academy of Ophthalmology. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Candy Simerson is the senior vice president of practice operations at Vision Integrated Partners. I. Paul Singh, MD, is the president of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He is a founding member of the band, Funkadesi, a mix of Indo-Afro-Caribbean style music. The band tours the world spreading the message “one family, many children.” We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for the Goldbergs, Simerson and Singh at the time of publication.

Abhishek Singh is a Ph.D. student at MIT Media Lab. His research interests include collective intelligence, self-organization, and decentralized machine learning. The central question guiding his research is --- how can we (algorithmically) engineer adaptive networks to build anti-fragile systems? He has co-authored multiple papers and built systems in machine learning, data privacy, and distributed computing. Before joining MIT, Abhishek worked with Cisco for 2 years where he did research in AutoML and Machine Learning for systems.An AbstractThe remarkable scaling of AI models has unlocked unprecedented capabilities in text and image generation, raising the question: why hasn't healthcare seen similar breakthroughs? While healthcare AI holds immense promise, progress has been stymied by fragmented data trapped in institutional silos. Traditional centralized approaches fall short in this domain, where privacy concerns and regulatory requirements prevent data consolidation. This talk introduces a framework for decentralized machine learning and discusses algorithms for enabling self-organization among participants with diverse resources and capabilities.About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

What if your brain could control augmented reality with just a thought? Imagine assistive devices empowering millions with ALS, stroke, or paralysis to communicate and interact like never before. Welcome to the Neurocareers: Doing the Impossible! podcast featuring visionary innovator Andreas Forsland, Founder and CEO of Cognixion.  A year ago, Andreas shared his entrepreneurial journey, giving us a behind-the-scenes look at Cognixion ONE—a groundbreaking brain-computer interface (BCI) headset that merges BCI and augmented reality (AR) to revolutionize assistive technology. Today, he's back with even more exciting updates! In this episode, Andreas dives into: The future of a $320B assistive reality market, addressing over 400 neurological conditions like ALS and autism. Cognixion's FDA-designated breakthrough device, a BCI-AR headset already making waves in major medical institutions. The convergence of brain signals, AI, AR, and assistive tech to create hands-free control for those with ALS, MS, and spinal cord injuries. The role of patents and intellectual property in shaping neurotech's future—Cognixion leads the way with over 50 global patents! Career opportunities in this fast-growing field and how your skills could fit into the transformative world of BCIs and assistive tech. Whether you're fascinated by neurotech, curious about AR's potential, or seeking insights into a career in assistive technology, this episode is for you! Andreas also touches on ethical considerations around privacy and security in a connected world, adding depth to this must-listen conversation. Tune in and join us on this journey into the future of neurotechnology, where innovation meets compassion, and possibilities are endless! About the Podcast Guest: Andreas Forsland, CEO of Cognixion https://www.cognixion.com/ LinkedIn: https://www.linkedin.com/in/andreasforsland/ Andreas Forsland is a visionary entrepreneur spearheading the future of human-computer interaction through advanced brain-computer interface (BCI) technology. He is the founder and CEO of Cognixion, the world's most accessible assisted reality wearable device with integrated BCI technology. Andreas' background in natural user experience design, customer experience, branding, and innovation allows him to embrace complexity and develop an interface and experience that is easily usable and understandable for researchers and patients alike. About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news © 2024 Neurocareers: Doing the Impossible! All rights reserved.

Zach Weinersmith is the cartoonist behind the popular geek webcomic, Saturday Morning Breakfast Cereal. He writes popular science books with his wife Kelly, including the recent Hugo award-winning A City on Mars. His work has been featured by The Economist, The Wall Street Journal, Slate, Forbes, Science Friday, Foreign Policy, PBS, Boingboing, the Freakonomics Blog, the RadioLab blog, Entertainment Weekly, Mother Jones, CNN, Discovery Magazine, Nautilus and more. Key HighlightsThe future of space governance is explored, focusing on rocketry, space settlements, international law, and challenges like closed-loop ecology and human reproduction.Zubrin's "The Case for Mars" is criticized for optimism, colonialist perspectives, and assumptions about sustainable environments on Mars.Physiological risks of space travel, including radiation, reduced gravity, and the lack of reproduction data, are highlighted.Lessons from Biosphere 2 and doubts about the economic and legal viability of Mars colonization are discussed.Debates cover the Moon Treaty, anti-space settlement arguments, and testing reproduction in partial gravity.About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs.Get Involved:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Our innovation experts Samuel Stephens, director, head of digital, nuclear at AtkinsRéalis and Angela MacOscar, director of innovation at Northumbrian Water, grill two innovators about their technology.  In this launch episode, recorded live at Techfest, they speak with FC Laboratories' Matthew Norbury about their AI-powered wearable neurotech to support brain fitness, and Matt Barney, chief hydrogen officer at Geopura about their Hydrogen Power Unit, designed to replace diesel generator power on site. Hydrogen power units have the potential to decarbonise construction activity by replacing diesel generators with green hydrogen. But how is the low carbon nature of that hydrogen assured and how site-ready are these new units?  Wearable fitness and safety technology has come a long way, so can brain fitness neurotech help improve wellbeing and safety by identifying fatigue and stress for those working on site and in potentially high risk roles?  Listen to our podcast to find out!

Jason Crawford is the founder of The Roots of Progress, a nonprofit dedicated to establishing a new philosophy of progress for the 21st century. He writes and speaks about the history and philosophy of progress, especially in technology and industry. Key HighlightsAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Steven Dell, MD, about his career and the creation of markets in the field of ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 29 1:28  Bausch + Lomb acquires Elios Vision 2:07  ImprimisRx awarded $34.9 million in trademark infringement suit against OSRX 5:00  Study of atropine-based myopia treatment fails to meet primary efficacy endpoint 7:31  Intro of Steven Dell, MD 11:20 You have created markets with new technologies and companies. Can that continue in today's market? 13:28 Dell discusses presbyopia market development. 14:11 You created a questionnaire that you used in your practice, which has become known as the Dell Questionnaire. What do we need to do better in treating our cataract patients? 16:20 What technologies are going to be the most important in the future? 20:24 What has changed in your office environment, i.e., the role of ODs, admin, staff? 22:00 Dell discusses Lindstrom's Integrated Eye Care Delivery Model. 23:08 What advice would you give a younger Steven Dell? 27:16 Neurotech Pharmaceuticals announced that chief commercial officer Scott Hunter died on Dec. 3. 33:06 Give us your feedback 34:43 Thanks 34:51 Steven J. Dell, MD, is a board-certified ophthalmologist in Austin and the Medical Director of Dell Laser Consultants. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Dell at the time of publication.

How is artificial intelligence transforming healthcare, and what new career opportunities are emerging at the intersection of AI and surgery? In this episode of Neurocareers: Doing the Impossible!, Milena Korostenskaja, PhD, interviews Daniel Donoho, MD, a pioneering pediatric and adult neurosurgeon at Children's National Hospital and George Washington University. Dr. Donoho discusses the role of AI in healthcare—what's possible now, the challenges that remain, and how to carve out a career in this innovative field. He explores how AI is reshaping surgery and healthcare delivery, from improving surgical training to enhancing patient outcomes. Dr. Donoho also highlights how AI can democratize surgical knowledge, especially in resource-limited regions, and addresses the challenges of AI adoption, including resistance to change and the need for interdisciplinary collaboration. He shares insights into emerging career opportunities at the intersection of AI and healthcare, offering guidance for those looking to enter this rapidly evolving industry. Join us as Dr. Donoho reflects on his career journey, the future of AI in medicine, and the exciting possibilities for professionals seeking to impact this transformative field. About the Podcast Guest: Daniel Donoho, MD, is a pediatric and adult neurosurgeon at Children's National Hospital and George Washington University, where he also serves as an assistant professor of pediatric neurosurgery. Dr. Donoho's career blends clinical expertise with groundbreaking work in surgical data science and artificial intelligence, focused on improving surgical outcomes worldwide. He is also the founder and president of the Surgical Data Science Collective (SDSC), a nonprofit organization dedicated to enhancing access to surgical data, particularly surgical videos, through machine learning to improve surgery outcomes globally. Dr. Donoho's academic journey began at Dartmouth College, where he earned an undergraduate degree in economics before pursuing a medical degree from SUNY-Stony Brook, where he was elected to the prestigious Alpha Omega Alpha Honor Medical Society. His early research in neuroendocrinology included studies on growth hormone replacement and oxytocin function. Following medical school, he completed his internship and residency in neurological surgery at the University of Southern California, gaining invaluable mentorship from renowned surgeons like Steven L. Giannotta, M.D., J. Gordon McComb, M.D., and Martin Weiss, M.D. During this time, he published over 50 manuscripts and book chapters and became a sought-after speaker on innovations in brain and spinal disorders. Dr. Donoho further honed his expertise with a prestigious fellowship in endoscopic, minimally disruptive surgery at Harvard Medical School under Edward R. Laws, Jr., M.D., specializing in skull base tumors. He then completed a fellowship in pediatric neurosurgery at Texas Children's Hospital, where he also served as a clinical instructor at Baylor College of Medicine. His clinical interests include brain and pituitary tumors, spinal disorders, hydrocephalus, myelomeningocele, and other complex pediatric conditions. In addition to his clinical work, Dr. Donoho leads research at the George Washington University School of Medicine and Health Sciences, the Children's National Center for Neuroscience Research, and the Sheikh Zayed Institute for Pediatric Surgical Innovation. His research focuses on surgical education and the integration of technological innovations to improve surgical safety. He founded one of the first neurosurgical computer vision research groups at USC and Caltech, where he remains actively involved in studying surgeon performance using computer vision and machine learning. Dr. Donoho's extensive experience in both clinical practice and cutting-edge research has positioned him at the forefront of AI and surgical data science, aiming to bridge the gap between healthcare and technology. His work continues to influence the future of surgery, healthcare access, and the integration of AI into clinical practice. A link to SDSC: https://www.surgicalvideo.io/ A link to Dr. Donoho's page at Children's National Hospital at Washington University: https://appointments.childrensnational.org/provider/daniel-aharon-donoho/2359746 A link to Dr. Donoho's page at George Washington School of Medicine and Health Science: https://smhs.gwu.edu/faculty-research/daniel-donoho-md  Connect with Dr. Donoho via LinkedIn: https://www.linkedin.com/in/danieldonoho/ Follow Dr. Donoho on X: https://x.com/ddonoho    About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news © 2024 Neurocareers: Doing the Impossible! All rights reserved.

Caleb Watney is the co-founder and co-CEO of IFP. He manages the metascience, high-skilled immigration, and emerging technology policy teams at IFP. His research focuses on policy levers the U.S. could use to rebuild state capacity and increase long-term rates of innovation. Previously, Caleb worked as the director of innovation policy at the Progressive Policy Insitute, a technology policy fellow at the R Street Institute, and a graduate research fellow at the Mercatus Center. Key HighlightsAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

In this special crossover episode, Eyeluminaries hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are joined live by Susan MacDonald, MD, and Cathleen McCabe, MD, at Eyecelerator 2024 in Chicago, IL. Intro :07 Welcome to the Eyeluminaries podcast 3:14 In this episode 5:02 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 5:11 What started you on this journey to do humanitarian work? 5:30 MacDonald discusses the role of parents in defining of happiness. 10:56 Hovanesian discusses the background of his humanitarian work in Armenia. 11:36 What about the funding of these humanitarian projects? 12:50 What are your stories from doing humanitarian work? 14:11 What advice to do you have for physicians who want to get involved in humanitarian work? 18:55 Hovanesian discusses the commonalities in MacDonald and McCabe's humanitarian missions. 22:23 McCabe discusses the commonalities in Hovanesian and MacDonald's humanitarian missions. 22:50 MacDonald discusses how her humanitarian work began. 23:28 Thank you. 27:05 MacDonald talks about the ophthalmic industry and their contribution to humanitarian work. 27:51 McCabe discusses ways physicians can get involved in humanitarian work without having to travel overseas. 28:42 Visit ACE Global, Cybersight or Operation Sight to get involved. 28:54 Mend the Gap podcast 30:49 Preview of episode 30 32:17 Give us your feedback 32:44 Thanks 33:17 Thoughts 33:27 Visit the ASCRS Foundation to get involved in Operation Sight. 34:20 Thank you for listening! 35:17 Don't forget to like and subscribe to Mend the Gap and Eyeluminaries! 35:39 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on X (formerly Twitter) @Healio_OSN. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. MacDonald and McCabe report no relevant financial disclosures.

Michael Levin is an American developmental and synthetic biologist at Tufts University, where he is the Vannevar Bush Distinguished Professor. Levin is a director of the Allen Discovery Center at Tufts University and Tufts Center for Regenerative and Developmental Biology. Key HighlightsDiscussion of diverse intelligence in biological systems and its biomedical potentialInsights into planarian regeneration and collective problem-solvingAnatomical plasticity and the role of bioelectric interfacesApplying these principles to regenerative medicine and synthetic biologyHow living structures can adapt and solve complex problems – leading to breakthroughs in organ regeneration, cancer treatment, and mental healthAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Is neurotech more exciting or terrifying? Is it a vehicle for optimizing our productivity or spying on is an a way humans never imagined? Joining me is Valentin Randon from Muse, a neurotech headset company that claims to have over 500,000 users. We pull no punches, as we go deep into philosophy to discuss the promising and perilous future of neurotechnology. Valentin Randon, the head of product at Muse, shares insights about the company's extensive brain data collection and its potential applications, including meditation, disease detection, and even thought recognition. We explore the philosophical and ethical implications of neurotech, the balance between thriving and privacy, and the intersection between personal growth, technology, and a dystopian future. 00:00 Intro 00:31 The Duality of Neurotech: Optimism and Fear(!) 03:17 Exploring the Potential and Risks of Brain Data 09:02 Personal Journey: Breaking Up with Tech  15:51 The Quest for Measuring Consciousness 20:37 The Paradox of Gamifying Zen and Higher Consciousness 24:01 The Paradox of Seeking Validation 29:19 The Balance Between Observation and Action 34:38 The Future of Wearable Technology 37:17 Philosophical Reflections on Technology and Society 40:30 Concluding Thoughts and Personal Reflections Subscribe to watch more videos https://choosemuse.com Watch the video of this episode: https://youtu.be/Eil-myltfMI

Zan Huang is a researcher with a passion for alternative computational models in artificial intelligence, mass social patterns, chaotic and emergent systems, and linguistics. Currently focused on scaling deep neural networks through neurologically inspired modularity, he explores critical questions around reducing parameter space, enhancing interpretability, and developing self-similar task divisions akin to brain functionality.Key HighlightsDiscussion of the adaptation of neurological structures for AI, proposing that neuroscience is crucial for understanding intelligence. Argument that certain principles of physics and mathematics apply to biological systems, like the brain, and that these can inform foundational models for AI. Exploration of concepts related to thermodynamics, information theory, and the fractal nature of intelligence. HPresentation of a neuro AI framework that emphasizes self-supervision, streamification, and task prioritization inspired by brain functionality to create more robust AI systems.About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

How can we record brain activity during natural behavior without bulky, restrictive devices? This question has challenged neuroscientists for years, but Saehyuck Oh and Janghwan Jekal from the Daegu Gyeongbuk Institute of Science and Technology (DGIST) have devised an innovative solution! In this episode of the BCI Award Neurocareers podcast series, we dive into the world of stealthy neural recording with their project, "Behavior to Byte: Stealthy Neural Recorder." The team has developed a fully wireless, battery-free, and implantable neural interface designed for primates, allowing researchers to study brain activity during natural behavior without interrupting the subject. This groundbreaking device combines soft bioelectronics for long-term implantation, enabling it to be safely placed deep within the brain for precise neural recording. Join us as Saehyuck and Janghwan share how their research tackles the challenges of developing implantable devices for primates—devices that must be durable, soft, and operate entirely without batteries. They'll also discuss the potential for this technology to revolutionize neurobehavioral research and offer valuable advice for anyone aspiring to submit a successful project for the BCI Award! Tune in to hear how their stealthy neural recorder is paving the way for more effective brain-behavior studies and changing the future of neural interfaces! About the Podcast Guests: Biography Saehyuck Oh received his B.E. degree in biomedical engineering from Yonsei University in 2019 and a M.S. degree in robotics engineering from Daegu Gyeongbuk Institute of Science and Technology (DGIST) in 2021. He is currently a Ph.D. candidate under the supervision of Prof. Kyung-In Jang in robotics and mechatronics engineering at DGIST, where research focuses on soft bioelectronics. His work focuses on developing wearable and implantable biomedical devices that can interface with biological systems for biomedical applications. Janghwan Jekal received his B.E. degree in School of Undergraduate Studies from Daegu Gyeongbuk Institute of Science and Technology (DGIST) in 2019. He is currently doing his Ph.D. degree under the supervision of Prof. Kyung-In Jang from robotics and mechatronics engineering at DGIST. His research focuses on implantable and wearable biomedical devices. Research work Activities such as exercising like riding a bicycle, taking deep breaths, eating, sleeping, experiencing sensations, controlling our weight, expending energy, and performing instinctive actions are all regulated by the brain. Each part of the brain is intricately connected, and the behaviors are the result of these complex processes. Therefore, to truly understand the origins of behavior, it is essential to measure and study brain neural activity. So, which animal model is most appropriate for studying the brain neural activity underlying natural behavior? Among the various experimental subjects, ranging from fish to humans, primates are the most suitable. Primates are genetically and anatomically similar to humans and possess high cognitive behavioral functions sililar to humans. So, what engineering elements are needed in a device to study the primate brain? Firstly, since monkeys can freely use their arms and legs and might can break the device, so it must be completely implanted. This necessitates the device to operate entirely wireless and without batteries, as it is impractical to charge or replace batteries in a monkey. Additionally, for long-term implantation, the neural probe must be soft to match the mechanical properties of living tissues. Since, brain regions associated with natural behaviors are located in the deep brain region, so the neural probe must be inserted into these deep brain regions. Also, the signals measured using these devices must undergo signal processing and artificial intelligence analysis to effectively link brain activity with behavior. To address these requirements, we have developed a wireless, battery-free and fully implantable brain neural interface for primates. You can read more about that in our Nature publication: https://www.nature.com/articles/s41551-024-01280-w About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news © 2024 Neurocareers: Doing the Impossible! All rights reserved.

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, are live from Eyecelerator with Mend the Gap hosts Susan MacDonald, MD, and Cathleen McCabe, MD, discussing their humanitarian work. Welcome to the Eyeluminaries podcast :02 In this episode :31 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 1:00 What started you on this journey to do humanitarian work? 2:18 MacDonald discusses the role of parents in defining of happiness. 7:47 Hovanesian discusses the background of his humanitarian work in Armenia. 8:24 What about the funding of these humanitarian projects? 9:38 What are your stories from doing humanitarian work? 10:59 What advice to do you have for physicians who want to get involved in humanitarian work? 15:43 Hovanesian discusses the commonalities in MacDonald and McCabe's humanitarian missions. 19:11 McCabe discusses the commonalities in Hovanesian and MacDonald's humanitarian missions. 19:38 MacDonald discusses how her humanitarian work began. 20:16 Thank you. 23:49 MacDonald talks about the ophthalmic industry and their contribution to humanitarian work. 24:39 McCabe discusses ways physicians can get involved in humanitarian work without having to travel overseas. 25:30 Visit ACE Global, Cybersight or Operation Sight to get involved. 25:38 Mend the Gap podcast 27:37 Preview of episode 30 29:05 Give us your feedback 29:25 Thanks 30:05 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. MacDonald and McCabe report no relevant financial disclosures.

Michael Levin is an American developmental and synthetic biologist at Tufts University, where he is the Vannevar Bush Distinguished Professor. Levin is a director of the Allen Discovery Center at Tufts University and Tufts Center for Regenerative and Developmental Biology. Key HighlightsDiscussion of diverse intelligence in biological systems and its biomedical potentialInsights into planarian regeneration and collective problem-solvingAnatomical plasticity and the role of bioelectric interfacesApplying these principles to regenerative medicine and synthetic biologyHow living structures can adapt and solve complex problems – leading to breakthroughs in organ regeneration, cancer treatment, and mental healthAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

What if your brainwaves could unlock doors, sign documents, and protect your most sensitive information without ever touching a keypad or fingerprint scanner? Welcome to a mind-bending episode of Neurocareers: Doing the Impossible! hosted by me, Milena Korostenskaja, a neurocareers coach and your guide into the world of neurotech! Today, I'm delighted to interview Violeta Tulceanu, a pioneering researcher from KU Leuven, Belgium, who stands at the forefront of brainwave authentication and neurotechnology security. In this episode, we dive deep into a world where your thoughts could become the next frontier in cybersecurity. But here's the kicker: what if your brain password revealed more than your identity? What if it exposed secrets about your emotions, health, or mental state? The stakes are incredibly high, and Violeta is here to unravel the fascinating—and complex—possibilities of using the human mind as a digital signature. Together, we'll discuss the career challenges she's encountered in this cutting-edge field, explore the ethical dilemmas of mind security, and tackle the technological hurdles of making brainwave authentication reliable and secure. Violeta will also share her insights into the evolving world of neuroethics and the philosophical questions that arise when we treat thoughts as credentials. Prepare to be amazed and maybe slightly unsettled as we journey into the thrilling—and sometimes unnerving—future of brain-computer interfaces and digital security. Tune in to Neurocareers: Doing the Impossible! Join us as we unlock the secrets of the mind with Violeta Tulceanu! This episode is a must-listen for anyone curious about the ever-evolving intersection of neuroscience, technology, and cybersecurity. About the Podcast Guest: Affiliation: Violeta Tulceanu is a doctoral researcher at KU Leuven, in the Computer Security and Industrial Cryptography (COSIC) department, working under the supervision of prof. Bart Preneel. KU Leuven, ESAT/COSIC, Kasteelpark Arenberg 10, bus 2452, B-3001 Leuven-Heverlee, Belgium. Violeta has a cryptography, neuroscience, AI background, and a dash of philosophy. Her research focuses on brainwave authentication, decoding and formally modeling thoughts, emotions, and cognitive processes, security of neurotechnologies and neurorights, pre-clinical diagnosis and monitoring of the collective mind, the applications of neurotechnologies in state security, the role of neurosemantics and neurotech in group 'war games,' creating dissent, rebellion and establishing or challenging the legitimacy of leadership. Also, she has an interest in brain-to-brain communications.  If you are interested in collaboration, I look forward to hearing from you! Contact information: vtulcean@esat.kuleuven.be Job opening for master student: https://www.ntxl.org/positions/microcontroller-expert---medtronic About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news © 2024 Neurocareers: Doing the Impossible! All rights reserved.  

Have you heard of temporal interference (TI) electrical stimulation, a revolutionary concept of non-invasive deep brain stimulation (DBS)? Curious about what it takes to develop cutting-edge neuromodulation techniques while pursuing a scientific career across two continents? Welcome to the Women in Neurotech series on the Neurocareers: Doing the Impossible! podcast!

Samuel Jardine is a Geopolitical Risk Consultant and Historian specializing in space, polar regions, and seabed security, utilizing Applied History and OSINT. He has lectured for institutions like RUSI and the Royal Navy, with publications by Routledge. Currently, he leads research at London Politica, advises Luminint, and contributes to the Lunar Policy Platform.Main PointsContext and an overview of AstropoliticsSpace law and governance: geopolitical issues, a Multipolar world, and competitionThe effects of the decoupling of US and ChinaCompeting Space Blocks: The Artemis Accords vs. ILRSChallenges and Opportunities in Space CooperationAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Anna Chekhovich is the financial director of Alexei Navalny's Anti-Corruption Foundation (FBK) from Russia. Targeted by Putin's regime, the foundation has gradually lost access to financial institutions. FBK has been using Bitcoin since 2015 to help overcome financial repression. At that time the Russian government began blocking the bank accounts of various foundations, even those very loosely connected to the FBK. Navalny and his family have also had their personal accounts frozen as did many people who worked on the FBK team. Bitcoin has given them a financial tool away from the reach of Putin's regime.About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Are you ready to boost your career in a unique way? Today's epsode is designed for anyone curious about starting a podcast—whether you want to explore it as a passion project, enhance your career, or dive into science communication. Welcome to a milestone moment – the 100th episode of Neurocareers: Doing the Impossible! For this special occasion, Milena Korostenskaja, host of Neurocareers, is stepping into the hot seat! Instead of hosting, Dr. K will be interviewed by one of her incredible former guests, Dr. Courtnie Paschall.         Joining the discussion pane are powerful podcasting experts: Stephen Hou, an amazing co-host of the Neurratives podcast; Harrison Canning, known as The BCI Guy and an inspiring science communicator; and Mike McClellan, a brilliant editor who brings the magic to Neurocareers behind the scenes. Together, they'll explore how to launch your own podcast and discuss how podcasting can elevate your career in science and tech, helping you build valuable networks, showcase your expertise, and make a real impact. As a special treat, you'll also hear us answering live questions from our audience! So, if you're thinking about starting a podcast or looking to take your show to the next level, join the panelists for practical tips, fresh ideas, and unique insights you won't find anywhere else (not even on ChatGPT!). Here's to the next step in your career – let's dive in! About the Podcast Panel: Courtnie Paschall, PhD A researcher and entrepreneur in neurotechnology and a former guest on Neurocareers: Doing the Impossible! takes the mic to interview podcast host Milena Korostenskaja and amazing podcasters in the neurotech field, Stephen Hou, Harrison Canning, and Mike McClellan, for the special 100th episode. Stephen Hou  Is an engineer at BlackRock Neurotech and co-host of Neurratives: A Podcast about Neuroscience in Fiction alongside Nick Halper. The show humorously explores neuroscience themes in popular media, with topics ranging from brain-computer interfaces in musicals to neuroethics in sci-fi films like JUNG_E. Harrison Canning  Is the creator of The BCI Guys, the host of the Brain Stream Podcast, a Neurotech Innovation Strategist at Blackrock Neurotech, and a Master's student at Harvard Medical School. Harrison focuses on neuroscience communication and was previously featured on Milena's Neurocareers podcast in an episode about his career in Science Communication.  Mike McClellan Is an aerospace engineer by day and podcast editor by passion. He is an extremely multi-talented guy – with degrees in physics, mechanical engineering, music composition, and music theory. He will offer insights into the technical side of podcast production. Milena Korostenskaja, PhD (Dr. K), is a scientist specializing in neuroimaging, brain-computer interfaces, and neurostimulation. She currently works as a BCI and Neurostimulation Scientist at g.tec medical engineering and offers career coaching through The Institute of Neuroapproaches. Dr. K also hosts the podcast “Neurocareers: Doing the Impossible!” About the Podcast: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 26 :58 FDA grants fast track designation to brepocitinib for noninfectious uveitis 1:42  I. Howard Fine, MD, esteemed ophthalmologist, dies 3:54 First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia 5:48 LENZ Therapeutics submits NDA for drops to treat presbyopia 7:57 Intro of Tom Mitro 10:40 Tell us about your journey in ophthalmology 12:38 Tell us about the new dry eye drug from Signal 12. 15:53 How much sensation is on the forehead if the drug is well tolerated? 24:13 What are your thoughts on the current ophthalmology market? 26:01 Tell us a funny story about Jim Mazzo and about John Hovanesian. 28:51 Preview of episode 29 33:25 Give us your feedback 34:34 Thanks 34:50 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Tom Mitro is the president and chief operating officer for Aerie Pharmaceuticals. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Mitro at the time of publication.

Molly Mackinlay has extensive work experience in various roles at different companies. She is currently the Head of Engineering, Product, & Research Development at Protocol Labs, where they lead teams working on the IPFS Project. Prior to this, Molly worked at Google where they held multiple roles including Google Search PM II, Google Forms PM, Google Classroom PM, and Associate Product Manager for Chrome Native Client. Before joining Google, she obtained their Bachelor's degree in Computer Science with a concentration in Human Computer Interaction from Stanford University. Key HighlightsExplores decentralized mechanisms for funding public goodsPresents three web3 experiments: Quadratic Funding, DAO treasuries, and Retroactive Public Goods RewardsIntroduces Open Impact Foundation as a legal structure for public goods fundingAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Send us a textAbout the guest: Nir Lipsman, MD, PhD is a neurosurgeon and neuroscientist at the University of Toronto.Episode summary: Nick and Dr. Lipsman discuss: neurosurgery; the blood-brain barrier and how it works; using focused ultrasound technology to non-invasively treat patients; regulatory impediments to clinical research; costs, constraints, and future applications of ultrasound tech for treating psychiatric conditions; and more.Related episodes:M&M #168: Sleep: Neural Circuits, Orexin/Hypocretin, Hypothalamus, Neuromodulators, Stress & Cortisol, Sleep Drugs & Ultrasound Technology | Luis de LeceaM&M #147: Ketamine: Opioid System, Sex Differences, S- vs. R- Isomers, Depression & Ultrasound Imaging Technology | Tommaso Di Ianni*This content is never meant to serve as medical advice.Support the showAll episodes (audio & video), show notes, transcripts, and more at the M&M Substack Affiliates: MASA Chips—delicious tortilla chips made from organic corn and grass-fed beef tallow. No seed oils, artificial ingredients, etc. Use code MIND for 20% off. SiPhox Health—Affordable, at-home bloodwork w/ a comprehensive set of key health marker. Use code TRIKOMES for a 10% discount. Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off. Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase. Learn all the ways you can support my efforts

Anders Sandberg's research centres on estimating the capabilities and underlying science of future technologies, methods of reasoning about long-term futures, existential and global catastrophic risk, the search for extraterrestrial intelligence (SETI), as well as societal and ethical issues surrounding human enhancement.Topics of particular interest include management of systemic risk, reasoning under uncertainty, enhancement of cognition, neuroethics and public policy. He has worked on this within the EU project ENHANCE, where he was also responsible for public outreach and online presence, and the ERC UnPredict project.Besides scientific publications in neuroscience, ethics and future studies he has also participated in the public debate about human enhancement, existential risk and SETI internationally.About Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

In this episode of The Cognitive Revolution, Nathan explores unconventional approaches to AI safety with Judd Rosenblatt and Mike Vaiana from AE Studio. Discover how this innovative company pivoted from brain-computer interfaces to groundbreaking AI alignment research, producing two notable results in cooperative and less deceptive AI systems. Join us for a deep dive into biologically-inspired approaches that offer hope for solving critical AI safety challenges. Self-Modeling: https://arxiv.org/abs/2407.10188 Self-Other Distinction Minimization: https://www.alignmentforum.org/posts/hzt9gHpNwA2oHtwKX/self-other-overlap-a-neglected-approach-to-ai-alignment Neglected approaches blog post: https://www.lesswrong.com/posts/qAdDzcBuDBLexb4fC/the-neglected-approaches-approach-ae-studio-s-alignment Apply to join over 400 Founders and Execs in the Turpentine Network: https://www.turpentinenetwork.co/ SPONSORS: WorkOS: Building an enterprise-ready SaaS app? WorkOS has got you covered with easy-to-integrate APIs for SAML, SCIM, and more. Join top startups like Vercel, Perplexity, Jasper & Webflow in powering your app with WorkOS. Enjoy a free tier for up to 1M users! Start now at https://bit.ly/WorkOS-Turpentine-Network Weights & Biases Weave: Weights & Biases Weave is a lightweight AI developer toolkit designed to simplify your LLM app development. With Weave, you can trace and debug input, metadata and output with just 2 lines of code. Make real progress on your LLM development and visit the following link to get started with Weave today: https://wandb.me/cr 80,000 Hours: 80,000 Hours offers free one-on-one career advising for Cognitive Revolution listeners aiming to tackle global challenges, especially in AI. They connect high-potential individuals with experts, opportunities, and personalized career plans to maximize positive impact. Apply for a free call at https://80000hours.org/cognitiverevolution to accelerate your career and contribute to solving pressing AI-related issues. Omneky: Omneky is an omnichannel creative generation platform that lets you launch hundreds of thousands of ad iterations that actually work customized across all platforms, with a click of a button. Omneky combines generative AI and real-time advertising data. Mention "Cog Rev" for 10% off https://www.omneky.com/ RECOMMENDED PODCAST: This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel ft their hottest takes on the future of tech, business, and venture capital. Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz CHAPTERS: (00:00:00) About the Show (00:00:22) Sponsors: WorkOS (00:01:22) About the Episode (00:05:18) Introduction and AE Studio Background (00:11:37) Keys to Success in Building AE Studio (00:16:57) Sponsors: Weights & Biases Weave | 80,000 Hours (00:19:37) Universal Launcher and Productivity Gains (00:24:44) 100x Productivity Increase Explanation (00:31:46) Brain-Computer Interface and AI Alignment (00:38:05) Sponsors: Omneky (00:38:30) Current State of NeuroTech (00:44:00) Survey on Neglected Approaches in AI Alignment (00:50:41) Self-Modeling and Biological Inspiration (00:57:48) Technical Details of Self-Modeling (01:06:17) Self-Other Distinction Minimization (01:12:44) Implementation in Language Models (01:19:00) Compute Costs and Scaling Considerations (01:24:27) Consciousness Concerns and Future Work (01:40:24) Evaluating Neglected Approaches (01:55:56) Closing Thoughts and Policy Considerations (01:59:25) Outro

In this episode of Brains Byte Back, we explore the future of neurotechnology with a special guest, Israel Gasperin, founder and CEO of Zentrela. Israel's company is leading the charge in using artificial intelligence (AI) to analyze brainwaves, developing groundbreaking tools that measure cognitive impairment in ways traditional drug tests can't. In 2018, the historic legalization of cannabis in Canada is where Zentrela really took off. With government funding and support in his research, he was able to create cutting-edge tools for effectively measuring cannabis impairment. Today, Zentrela's AI-based EEG technology is being used globally to help a variety of industries, including cannabis, energy drinks, and wellness, conduct faster, more cost-effective product testing – giving consumers direct insight into the psychoactive and non-psychoactive effects of the products they are buying. They are essentially providing companies and consumers with a new kind of label—not the traditional listing of ingredients but rather the effects of the product. The future of brainwave analysis is shaping the way companies research, develop, and inform their customers like never before—Israel shares how.  Find out more about Israel Gasperin here (Linkedin) -  https://www.linkedin.com/in/israelgasperin/ Find out more about Zentrela (website) -  https://zentrela.com/ Brains Byte Back: Reach out to today's host, Erick Espinosa (Linkedin) -  linkedin.com/in/erick-espinosa Get the latest on tech news - https://sociable.co/  Leave an iTunes review  - https://rb.gy/ampk26 Follow us on your favourite podcast platform - https://link.chtbl.com/rN3x4ecY Find out more about our sponsor Publicize - https://publicize.co/startup-resources/

Greg and Matias interview Tim Marjenin, a regulatory consultant at MCRA with 16 years of experience at the FDA, to discuss the regulatory landscape for neurotechnology devices.Tim provides insights into the FDA approval process for neurotech devices, drawing from his extensive experience on the FDA's Neurostimulation-Neurology Devices Team. The episode explores the evolving field of neurotechnology and its regulatory challenges.In this episode, we discuss:Different regulatory pathways for neurological devices (510(k), De Novo, PMA)FDA's approach to novel neurotechnologies like brain-computer interfaces (BCIs)Considerations for invasive vs. non-invasive neurotech devicesThe importance of cybersecurity in neurotechnologyCommon mistakes companies make in the regulatory process and how to avoid themThe potential future of neurotechnology, including human augmentation and telepathyCreated by Greg Kubin and Matias SerebrinskyHost: Matias Serebrinsky & Greg KubinProduced by Jonathan A. Davis,  Nico V. Rey & Caitlin NerFind us at businesstrip.fm and psymed.venturesFollow us on Instagram and Twitter!Theme music by Dorian LoveAdditional Music: Distant Daze by Zack Frank and Krotoa by Makropulos